The application belongs to the field of biological
medicine, and discloses a pharmaceutical composition of
water channel protein inhibitor combined with
temozolomide for treating
brain glioma, wherein the pharmaceutical composition comprises AQP4 inhibitor AER270 and TMZ. The application further discloses a pharmaceutical preparation comprising the above pharmaceutical composition and application of the pharmaceutical preparation in preparation of a
medicine for treating
brain glioma. The composition provided by the application provides an effective
drug combination strategy for treating
brain glioma, and it is found for the first time that AER270 and TMZ have a synergistic effect on the treatment of brain
glioma.